Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 5 42-5, 1997, Pages

  Wang, Cindy ^a   Ford, Philbert ^a   Chao, Caroline ^a   Lee, Chao ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Blood pressure; Northern blot; Radioimmunoassay; Wistar rat

Indexed keywords

BRADYKININ B2 RECEPTOR; CYCLOSPORIN A; KALLIKREIN; KININOGEN; MESSENGER RNA; SESAME SEED OIL; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GENE EXPRESSION; HYPERTENSION; KALLIKREIN KININ SYSTEM; KALLIKREIN URINE LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASOCONSTRICTION;

EID: 0030709457     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.273.5.f783     Document Type: Article

References (20)

1. Alfie, M. E., X. P. Yang, F. Hess, and O. A. Carretero. Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem. Biophys. Res. Commun. 224: 625-630, 1996.
2. Amore, A., B. Gianoglio, D. Ghigo, L. Peruzzi, M. G. Porcellini, F. Bussolino, C. Costamagna, G. Cacace, G. Picciotto, G. Mazzucco, L. M. Sena, and R. Coppo. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int. 47: 1507-1514, 1995.
3. Bantle, J. P., R. J. Bourreau, and T. F. Ferris. Suppression of plasma renin activity by cyclosporine. Am. J. Med. 83: 59-65, 1987.
4. Bennett, W. N., and G. A. Porter. Cyclosporine-associated hypertension. Am. J. Med. 85: 131-133, 1988.
5. Berry, T. D., S. J. Hasstedt, S. C. Hunt, L. L. Wu, J. B. Smith, K. O. Ash, H. Kuida, and R. R. Williams. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13: 3-8, 1989.
6. Bhoola, K. D., C. D. Figueroa, and K. Worthy. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44: 1-80, 1992.
7. Bompart, G., I. Tack, E. M. Castano, J. B. Pesquero, J. P. Girolami, and J. L. Bascands. Cyclosporine A decreases kallikrein and BK2 mRNA expression in the rat renal cortex. Immunopharmacology 32: 99-101, 1996.
8. Chao, C., P. Madeddu, C. Wang, Y. M. Liang, L. Chao, and J. Chao. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F78-F86, 1996.
9. Chao, J., K. X. Chai, L. M. Chen, W. Xiong, S. Chao, C. Woodley-Miller, L. Wang, H. S. Lu, and L. Chao. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J. Biol. Chem. 265: 16394-16401, 1990.
10. Chao, J., and H. S. Margolius. Isozymes of rat urinary kallikrein. Biochem. Pharmacol. 28: 2071-2079, 1979.
11. Chao, S., K. X. Chai, L. Chao, and J. Chao. Molecular cloning and primary structure of rat a1-antitrypsin. Biochemistry 29: 323-329, 1990.
12. 2 kinin-binding sites in two-kidney, one-clip hypertensive rats. Am. J. Physiol. 260 (Renal Fluid Electrolyte Physiol. 29): F626-F634, 1991.
13. Fenoy, F. J., and R. J. Roman. Effect of kinin receptor antagonists on renal hemodynamic and natriuretic responses to volume expansion. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R1136-R1140, 1992.
14. Gerald, W. L., J. Chao, and L. Chao. Immunological identification of rat tissue kallikrein cDNA and characterization of the kallikrein gene family. Biochim. Biophys. Acta 866: 1-14, 1986.
15. Granger, J. P., and J. E. Hall. Acute and chronic actions of bradykinin on renal function and arterial pressure. Am. J. Physiol. 248 (Renal Fluid Electrolyte Physiol. 17): F87-F92, 1985.
16. Kaye, D., J. Thompson, G. Jennings, and M. Esler. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Hypertension 88: 1101-1109, 1993.
17. Lamb, F. S., and R. C. Webb. Cyclosporine augments reactivity of isolated blood vessels. Life Sci. 40: 2571-2578, 1987.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
19. Madeddu, P. Receptor antagonists of bradykinin: a new tool to study the cardiovascular effects of endogenous kinins. Pharmacol. Rev. 28: 107-128, 1993.
20. Margolius, H. S., R. Geller, W. De Jong, J. J. Pisano, and A. Sjoerdsma. Altered urinary kallikrein excretion in rats with hypertension. Circ. Res. 30: 358-362, 1972.